Methotrexate

Methotrexate is an organic compound with the chemical formula C20H22N8O5. It is mainly used as an anti-folate anti-tumor drug. By inhibiting dihydrofolate reductase, it can hinder the synthesis of tumor cells and inhibit the growth and reproduction of tumor cells.

Appearance: yellow crystalline powder.

Solubility: Soluble in dilute alkali, acid or alkali metal carbonate solution, slightly soluble in dilute hydrochloric acid, almost insoluble in water, ethanol, chloroform, ether.

Methotrexate is an antifolic acid antitumor drug, which has an inhibitory effect on many animal tumors. Experiments have shown that this drug works by competitive inhibition of dihydrofolate reductase. Dihydrofolate reductase is an important enzyme in DNA synthesis, especially in the conversion of folate to tetrahydrofolate and the methylation of deoxyuracil nucleoside to thymine nucleoside. This drug selectively acts on the DNA synthesis phase (that is, S phase), and is a cycle-specific drug. Recently, it has been suggested that this product has a second action point, that is, the G1/S transition phase, it can also inhibit the synthesis of interleukin-2 and inhibit the chemotactic effect of neutrophils, so it has immunosuppressive and anti-inflammatory effects. In large doses, it also has direct toxic effects on non-proliferating cells, especially hepatocytes, and CF is commonly used as an antidote in clinic.
The structure of methotrexate (MTX) is similar to folic acid, and the hydroxy group at 4 and the hydrogen at 10 NH are amino and CH3 respectively in MTX. MTX binds to dihydrofolate reductase, blocking the reduction of folate and dihydrofolate to activated tetrahydrofolate, thus inhibiting intracellular one-carbon transfer, affecting purine synthesis and deoxyuracil nucleotide conversion to deoxythymine nucleotide, and blocking DNA and RNA synthesis. MTX, at concentrations of 10-8mol/L in plasma, can effectively block the incorporation of deoxyuracil nucleotides into DNA via deoxythymine nucleotides, while inhibiting purine synthesis at concentrations of 10-7mol/L. The binding of MTX to dihydrofolate reductase is reversible but firm. The amount of dihydrofolate is 1000 times higher than MTX to resist MTX binding. In vitro, MTX can induce the differentiation of human chorionic epithelial cancer cells and increase the production of chorionic gonadotropin when the concentration is lower than that which completely inhibits DNA synthesis. MTX is a cell cycle specific drug, which mainly acts on S phase cells, has some effect on G1 phase, and has a delaying effect on G1/S.

当社は、緊密な協力関係にある多くの高品質の工場を有しており、高品質の製品と競争力のある価格を提供できます。また、大量購入には割引も提供できます。また、当社は多くの専門の貨物運送会社と協力し、製品を安全かつスムーズにお客様の手元に届けることができます。納期は、支払い確認後約3〜20日です。

1. 貴社は工場ですか、それとも貿易会社ですか?
当社は産業と貿易を統合し、ワンストップサービスを提供する会社です。OEMも受け付けております。

2. サンプルは提供されますか? 無料ですか、それとも追加料金がかかりますか?
サンプルは無料です。サンプルの送料はお客様負担となります。

3. 品質管理に関する証明書はありますか?
品質を保証する ISO 9001:2008 認証。

4. 見積もりを取得するには、何を提供すればよいですか?
必要な製品タイプ、注文数量、住所、具体的な要件をお知らせください。参考用に見積書をすぐに作成いたします。

5. どのような支払い方法をご希望ですか? どのような条件が受け入れられますか?
受け入れられる配送条件: FOB、CFR、CIF、EXW。
受け入れられる支払い通貨：USD;
受け入れられる支払いタイプ: T/T、Western Union、Paypal、Trade Assurance。
使用言語：英語。